MedPath
FDA Approval

Oxandrolone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 1, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Oxandrolone(2.5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Pharmaceutics Internatonal Inc.

Upsher-Smith Laboratories, LLC

878265586

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxandrolone

Product Details

NDC Product Code
0245-0271
Application Number
ANDA076761
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 1, 2020
anhydrous lactoseInactive
Code: 3SY5LH9PMKClass: IACT
starch, cornInactive
Code: O8232NY3SJClass: IACT
Code: 7H6TM3CT4LClass: ACTIBQuantity: 2.5 mg in 1 1
hypromellose, unspecifiedInactive
Code: 3NXW29V3WOClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath